←Back to list

Virta Health

Telehealth diabetes and obesity reversal via ketogenic nutrition and coaching
Virta Health is a telehealth program that reverses type 2 diabetes and obesity using ketogenic nutrition and physician-led coaching. Co-founded by Sami Inkinen (CEO), Stephen Phinney, and Jeff Volek in 2014, the Denver-based company crossed $160M in annualized revenue in September 2025 (up ~49% YoY) serving employers and health plans. Valued at $2B in 2024.
Digital Health 📍 Denver, CO Founded 2014
Current Valuation
$2.0B
as of 2024
UNICORN

QL Price

$2.0B
0% vs last round
QuantLogix's current estimate for Virta Health, published 2026-10-07 — in line with the last disclosed round of $2.0B (2024).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round $2.0B 2024 weight 0.29
How this price has held up
No round has priced for Virta Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-10-07 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Virta Health →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Virta Health, 2026-10-07 (a52556632348f537). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookrumored

Is Virta Health going public?
An IPO is rumored, with nothing filed. Virta Health remains private and the date is not the company's.
What is Virta Health's valuation in 2026?
Virta Health is valued at $2.0B as of 2024, set by its Series E ($133M, Jan 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Virta Health filed an S-1?
No public S-1 is on file for Virta Health as of 10/07/2026; the IPO is rumored.
Who are Virta Health's investors?
Virta Health's investors include Tiger Global, Sequoia Capital, Caffeinated Capital, Venrock, Founders Fund, Ahren Innovation Capital.
How much has Virta Health raised?
Virta Health has raised $364.5M in total, most recently a Series E of $133M in Jan 2021.
Is Virta Health publicly traded — can you buy Virta Health stock?
No. Virta Health is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Virta Health on its Pre-IPO Access Desk.
How to actually get exposure to Virta Health →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

CEO
Sami Inkinen
Founded
2014
HQ
Denver, CO
Employees
~800
Total Raised
$364.5M
Est. Revenue
$160M (2025)
Growth
+49% YoY (~$160M ARR)
Last Round
Series E — $133M (Jan 2021) · Lead: Tiger Global
IPO Status
rumored

Fundraising Status

Series E · $133M · 5y 9mo ago
rumoredTotal raised $364.5M

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series E$133MJan 2021Tiger Global—

Talent Signal

Hiring trend
▲ Hiring uptrend
+50% vs 2026-08
Open roles
24
via ashby
Product-build share
38%
engineering, research, product, design
Trajectory
expanding
balanced build + GTM — 38% builders vs 62% go-to-market/G&A — scaling both sides.
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by month16Aug '2624Sep '26
Open roles by function
Open roles by functionEngineering8Other5Legal & Policy3Sales & GTM2Finance & Strategy2Marketing2Data & ML1Ops & People1
■ product-building   ■ go-to-market / G&A
AI Operations EngineerEngineering Manager, Product Platform Senior Software Engineer IISoftware EngineerIT EngineerSenior Engineering Manager - Client Group
Counted from Virta Health's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.

Founders & Key People

Sami InkinenStephen PhinneyJeff Volek

Investors

Tiger Global · Sequoia Capital · Caffeinated Capital · Venrock · Founders Fund · Ahren Innovation Capital

Products

  • Type 2 diabetes reversal program
  • Obesity reversal program
  • GLP-1 augmentation program
  • Continuous glucose monitor + coaching
  • Employer + payer telehealth platform

Competitors

Omada Health · Livongo (Teladoc) · Hinge Health · Noom · Calibrate
b2btelehealthdigital-healthmetabolic-diseaseGLP-1
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024. Refreshed quarterly.